Compare Merck & Co., Inc. (MRK) vs PayPal Holdings, Inc. (PYPL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck & Co., Inc. vs PayPal Holdings, Inc. — how do they compare? Merck & Co., Inc. trades at $148.23 (market cap $366.28B), while PayPal Holdings, Inc. trades at $52.2 (market cap $45.49B). The key difference: Merck & Co., Inc. is far larger — about 8.1× PayPal Holdings, Inc.'s market cap, and Merck & Co., Inc. pays the higher dividend (2.29%). Which is the better fit depends on your goals.
| MRK | PYPL | |
|---|---|---|
Market Cap | $366.28B | $45.49B |
Sector | Health | Financials |
52-Week High | $156.43 | $76.13 |
52-Week Low | $77.60 | $39.08 |
Enterprise Value | $413.04B | $47.64B |
Dividend Yield | 2.29% | 1.05% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MRK trades at $148.49, down 1.23% on the day, with a bullish technical signal from moving averages and support near $147. The company reported strong earnings beats in recent quarters, with Q3 2026 EPS expected at $2.22. Revenue reached $65.01B in 2025, and the acquisition of Terns Pharmaceuticals aims to bolster its oncology pipeline.
Outlook remains positive with a consensus price target of $157, offering ~6% upside. Risks include high P/E of 118.77 and competitive pressures in pharma. Institutional buying and a 67.57% buy rating from analysts support a constructive view, though net income margin of 4.77% warrants monitoring.
PayPal (PYPL) trades at $53.18, down 3.24% on the day, with a bearish technical outlook but strong fundamentals including a P/E of 10.05 and net income margin of 14.36%. Recent earnings beat expectations in Q1 and Q2 2026, while the company pursues a $1.5B cost-saving initiative and expands beyond branded checkout. Analyst consensus is a $59.61 price target with a mixed rating distribution.
The stock presents a value opportunity given low valuation multiples and solid profitability, but faces headwinds from competitive pressures and recent takeover speculation collapse. Upside depends on successful execution of restructuring and new growth initiatives, while downside risks include market sentiment shifts and execution missteps.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →About PayPal Holdings, Inc.
PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.
Read more on PYPL →
